Ohio introduced a legalization bill, cannabis and psilocybin could be the future of cancer care, and a ketamine company is looking to take the lead in the space.
Let’s dive into this week’s canna-news.
Ohio Eyes Legalization With HB 168
Ohio is inching closer to making cannabis legalization a reality. The bipartisan-backed House Bill 168—the Ohio Adult Use Act—is looking to legalize the cultivation, purchase, and possession of cannabis for individuals aged 21 and older. If passed, the bill would also expunge the records of those convicted on cultivation and possession charges.
HB 168 includes a 10% sales tax on recreational cannabis purchases. According to researchers at Ohio State University, the sales tax could help generate up to $374 million for the state in the first 5 years of operation.
Lastly, HB 168 also proposes some changes to Ohio’s current Medical Marijuana Control Program, starting with a rebrand. The office will be renamed to the Division of Marijuana Control. The renamed division will be tasked with overseeing the new recreational market and its associated programs should the bill pass.
What do you think of the push for legalization going on in Ohio? Let us know in the comments!
Apply For Your Medical Marijuana Card Today
Veriheal has satisfied hundreds of thousands of patients nationwide
Get approved or your money back
Appointments available on-demand
Customer support available 24/7
CaaMTech Rethinks the Future of Cancer Care
Washington-based cannabinoid laboratory CaaMTech is looking to revolutionize the future of cancer care with psilocybin and cannabis. The company is currently conducting research on how these substances interact and complement each other. Researchers hope to find the ratio of cannabis and psilocybin that maximizes each substance’s benefits.
There is growing anecdotal evidence showing just how effectively cannabis and psilocybin can treat folks with cancer. Most recently, a 49-year-old woman experienced a noticeable reduction in the size of her tumor after taking cannabis and psilocybin together. The woman’s results, along with other similar cases, indicate that the combo may be effective in reducing tumor inflammation while reducing the psychological distress experienced by many during chemotherapy.
What do you think of CaaMTech’s ambitious research endeavor? Do you think cannabis and psilocybin are the future of cannabis care? Let us know in the comments!
Ketamine Company Continues Expansion
As ketamine continues to gain legitimacy as an alternative medicine, one company is ramping up to become a leader in the space.
Chose Ketamine is a wellness platform offering at-home ketamine therapy. The company recently extended its service area to include Arizona, Connecticut, Georgia, and Michigan. With this expansion, Choose Ketamine can now help an additional 31.7 million Americans get the help they need. As a whole, Choose Ketamine now serves over 50% of the U.S. population!
Next up, Choose Ketamine is looking to expand into Oregon, Pennsylvania, New York, and Tennessee.
Mexico-born and California-raised, Cesar is a Marketing Associate at Veriheal. When he’s not scouring social media for the latest internet drama, you can find him working on yet another collage project.
Suddenly, the world of magic mushrooms is almost as complicated as that of learning about cannabis. Shrooms or “magic” mushrooms have gained traction as a hallucinogenic therapeutic application for several different mental health circumstances such as depression and migraines—particularly when microdosing. It’s not just liberty caps anymore, folks. There are many different varieties and types…
Edibles are arguably one of the best means of recreational cannabis consumption—you get to eat a treat AND experience a long-lasting high. But it’s easy to end up dealing with some unwanted side effects due to the variability in the onset of these THC-packed goodies, which come in the form of brownies, cookies, gummies, chocolate,…
If you’re reading this, you are either a recreational cannabis veteran who has seen a handful of cannabis smokers passing out from puffing a joint and can’t seem to figure out why. Or, you are a newbie who wants to give recreational or medical cannabis a shot, and the burning question on your mind is,…
When you decide that you are going to dabble in cannabis cultivation, you have many different decisions to make. You’ll have to decide whether you’re growing indoors or outdoors, as well as in soil, or the route of hydroponics. You’ll also have to pick what type of planters to use, what grow medium to use,…
A survey illustrates psychedelics’ rapid rise, Herer Brands sues Daniel Herer, and Hulkamania comes to cannabis. Let’s dive into this week’s canna-news. Psychedelic Use Reaches Record High A new national survey conducted by Monitoring The Future found that psychedelic use is at an all-time high amongst U.S. adults. Conducted in 2022, the survey included approximately…
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.